115 related articles for article (PubMed ID: 31760050)
21. A Cost Analysis of Gyrase A Testing and Targeted Ciprofloxacin Therapy Versus Recommended 2-Drug Therapy for Neisseria gonorrhoeae Infection.
Allan-Blitz LT; Hemarajata P; Humphries RM; Wynn A; Segura ER; Klausner JD
Sex Transm Dis; 2018 Feb; 45(2):87-91. PubMed ID: 29329176
[TBL] [Abstract][Full Text] [Related]
22. Molecular Assay for Detection of Genetic Markers Associated with Decreased Susceptibility to Cephalosporins in Neisseria gonorrhoeae.
Peterson SW; Martin I; Demczuk W; Bharat A; Hoang L; Wylie J; Allen V; Lefebvre B; Tyrrell G; Horsman G; Haldane D; Garceau R; Wong T; Mulvey MR
J Clin Microbiol; 2015 Jul; 53(7):2042-8. PubMed ID: 25878350
[TBL] [Abstract][Full Text] [Related]
23. Trends in antimicrobial resistance of Neisseria gonorrhoeae isolated from Korean patients from 2000 to 2006.
Lee H; Hong SG; Soe Y; Yong D; Jeong SH; Lee K; Chong Y
Sex Transm Dis; 2011 Nov; 38(11):1082-6. PubMed ID: 21992988
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous Detection of Neisseria gonorrhoeae and Fluoroquinolone Resistance Mutations to Enable Rapid Prescription of Oral Antibiotics.
de Korne-Elenbaas J; Pol A; Vet J; Dierdorp M; van Dam AP; Bruisten SM
Sex Transm Dis; 2020 Apr; 47(4):238-242. PubMed ID: 32022739
[TBL] [Abstract][Full Text] [Related]
25. TaqMan real-time quantitative PCR assay for detection of fluoroquinolone-resistant Neisseria gonorrhoeae.
Zhao L; Zhao S
Curr Microbiol; 2012 Dec; 65(6):692-5. PubMed ID: 22941436
[TBL] [Abstract][Full Text] [Related]
26. Analysis of mutations within multiple genes associated with resistance in a clinical isolate of Neisseria gonorrhoeae with reduced ceftriaxone susceptibility that shows a multidrug-resistant phenotype.
Tanaka M; Nakayama H; Huruya K; Konomi I; Irie S; Kanayama A; Saika T; Kobayashi I
Int J Antimicrob Agents; 2006 Jan; 27(1):20-6. PubMed ID: 16318912
[TBL] [Abstract][Full Text] [Related]
27. Verification of clinical samples, positive in AMPLICOR Neisseria gonorrhoeae polymerase chain reaction, by 16S rRNA and gyrA compared with culture.
Airell A; Lindbäck E; Ataker F; Pörnull KJ; Wretlind B
Int J STD AIDS; 2005 Jun; 16(6):415-9. PubMed ID: 15969775
[TBL] [Abstract][Full Text] [Related]
28. High-frequency of quinolone-resistant Neisseria gonorrhoeae in Austria with a common pattern of triple mutations in GyrA and ParC genes.
Uthman A; Heller-Vitouch C; Stary A; Bilina A; Kuchinka-Koch A; Söltz-Szöts J; Tschachler E
Sex Transm Dis; 2004 Oct; 31(10):616-8. PubMed ID: 15389000
[TBL] [Abstract][Full Text] [Related]
29. [Correlation between mutation of GyrA and ParC genes and quinolone resistance in Neisseria gonorrhoeae].
Xie P; Mi ZH; Li Q; Zhang J; Xiao CY
Zhonghua Nan Ke Xue; 2003; 9(4):275-8. PubMed ID: 12931370
[TBL] [Abstract][Full Text] [Related]
30. Quinolone resistance in Neisseria gonorrhoeae: rapid genotyping of quinolone resistance-determining regions in gyrA and parC genes by melting curve analysis predicts susceptibility.
Vernel-Pauillac F; Hogan TR; Tapsall JW; Goarant C
Antimicrob Agents Chemother; 2009 Mar; 53(3):1264-7. PubMed ID: 19124663
[TBL] [Abstract][Full Text] [Related]
31. DNA gyrase gene in Neisseria gonorrhoeae as indicator for resistance to ciprofloxacin and species verification.
Lindbäck E; Gharizadeh B; Ataker F; Airell A; Jalal S; Nyrén P; Wretlind B
Int J STD AIDS; 2005 Feb; 16(2):142-7. PubMed ID: 15807943
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the gyrA and parC genes of quinolone-resistant Neisseria gonorrhoeae isolates in India.
Kulkarni S; Bala M; Sane S; Pandey S; Bhattacharya J; Risbud A
Int J Antimicrob Agents; 2012 Dec; 40(6):549-53. PubMed ID: 23063097
[TBL] [Abstract][Full Text] [Related]
33. Rapid detection of quinolone resistance-associated gyrA mutations in Neisseria gonorrhoeae with a LightCycler.
Li Z; Yokoi S; Kawamura Y; Maeda S; Ezaki T; Deguchi T
J Infect Chemother; 2002 Jun; 8(2):145-50. PubMed ID: 12111567
[TBL] [Abstract][Full Text] [Related]
34. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
[TBL] [Abstract][Full Text] [Related]
35. Using the Neisseria gonorrhoeae multiantigen sequence-typing method to assess strain diversity and antibiotic resistance in San Francisco, California.
Buono S; Wu A; Hess DC; Carlson JS; Rauch L; Philip SS; Barry P; Bernstein K; Klausner JD; Pandori MW
Microb Drug Resist; 2012 Oct; 18(5):510-7. PubMed ID: 22686196
[TBL] [Abstract][Full Text] [Related]
36. Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.
Jabeen K; Bhawan Mal P; Khan E; Chandio S; Jacobsson S; Unemo M
BMC Infect Dis; 2016 Jul; 16():353. PubMed ID: 27449234
[TBL] [Abstract][Full Text] [Related]
37. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.
Jiang FX; Lan Q; Le WJ; Su XH
BMC Infect Dis; 2017 May; 17(1):366. PubMed ID: 28545411
[TBL] [Abstract][Full Text] [Related]
38. High occurrence of simultaneous mutations in target enzymes and MtrRCDE efflux system in quinolone-resistant Neisseria gonorrhoeae.
Dewi BE; Akira S; Hayashi H; Ba-Thein W
Sex Transm Dis; 2004 Jun; 31(6):353-9. PubMed ID: 15167645
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial resistance of Neisseria gonorrhoeae in Japan, 1993-2002: continuous increasing of ciprofloxacin-resistant isolates.
Tanaka M; Nakayama H; Notomi T; Irie S; Tsunoda Y; Okadome A; Saika T; Kobayashi I
Int J Antimicrob Agents; 2004 Sep; 24 Suppl 1():S15-22. PubMed ID: 15364300
[TBL] [Abstract][Full Text] [Related]
40. Characterization of ciprofloxacin resistance in Neisseria gonorrhoeae isolates in Canada.
Ng LK; Sawatzky P; Martin IE; Booth S
Sex Transm Dis; 2002 Dec; 29(12):780-8. PubMed ID: 12466720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
